These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 8233265
1. A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women. Hickok LR, Toomey C, Speroff L. Obstet Gynecol; 1993 Dec; 82(6):919-24. PubMed ID: 8233265 [Abstract] [Full Text] [Related]
3. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women. Warnock JK, Swanson SG, Borel RW, Zipfel LM, Brennan JJ, ESTRATEST Clinical Study Group. Menopause; 2005 Dec; 12(4):374-84. PubMed ID: 16037752 [Abstract] [Full Text] [Related]
7. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium. Khoo SK, Coglan MJ, Wright GR, DeVoss KN, Battistutta D. Med J Aust; 1998 Mar 02; 168(5):216-20. PubMed ID: 9539899 [Abstract] [Full Text] [Related]
15. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women. Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K. Climacteric; 2002 Dec 02; 5(4):341-50. PubMed ID: 12626213 [Abstract] [Full Text] [Related]
16. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy. Ylikorkala O, Lim P, Caubel P. Clin Ther; 2000 May 02; 22(5):622-36. PubMed ID: 10868559 [Abstract] [Full Text] [Related]
17. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women. Davidson MH, Testolin LM, Maki KC, von Duvillard S, Drennan KB. Arch Intern Med; 1997 Jun 09; 157(11):1186-92. PubMed ID: 9183229 [Abstract] [Full Text] [Related]
18. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms. de Paula FJ, Soares JM, Haidar MA, de Lima GR, Baracat EC. Maturitas; 2007 Jan 20; 56(1):69-77. PubMed ID: 16822626 [Abstract] [Full Text] [Related]
19. Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone. Meuwissen JH, Beijers-De Bie L, Vihtamaki T, Tuimala R, Siseles N, Magaril C, The HS, Houben PW, Murga M, Spielmann D, De Villiers TJ. Gynecol Endocrinol; 2002 Apr 20; 16(2):155-62. PubMed ID: 12012627 [Abstract] [Full Text] [Related]
20. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ. Obstet Gynecol; 1995 Apr 20; 85(4):529-37. PubMed ID: 7898828 [Abstract] [Full Text] [Related] Page: [Next] [New Search]